PrescribeToPrevent

Prescribe Naloxone, Save a Life

  • Clinician Resource
    • General
    • Emergency Medicine
    • Substance Use Disorder Treatment
  • OTC Naloxone
  • Patient Education
    • Videos
    • Online Training
    • Materials
  • Policy Resources
    • Research
    • Legal
    • Position Statements
  • FAQ
  • Contact Us

08.18.18

PubMed Update March-June 2018

Life is busy and so are all these writers – 109 papers. This is four months of article updates so a bit overwhelming. Sorry about that. I tried to help by creating some categories, but there are still 35 uncategorized.   26 naloxone papers:   1) Naloxone prescriptions from the emergency department: An initiative in evolution.Read More

03.30.18

PubMed Update February 2018

36 papers this month. I will add that this is a PubMed literature review – we cover published articles. This month, unfortunately, an unpublished paper of very poor methodology with multiple major errors got a lot of attention. I won’t provide the link here so as to avoid drawing further attention to the paper. ItRead More

01.06.18

PubMed Update December 2017 – January 2018

57 for the past two months, from new ways to look at medical examiner data to an unfortunate complication of resuscitation. The fentanyl papers are at the end, as are a couple papers each addressing safe consumption spaces and opioid reformulations.   1) Wearable Biosensors to Evaluate Recurrent Opioid Toxicity After Naloxone Administration: A Hilbert Transform Approach.Read More

11.10.17

PubMed Update September-October 2017

51 in two months, continuing to run solid.   1) Using Group Visits to Provide Overdose Education and Distribute Naloxone to High-Risk Primary Care Patients. Bair MJ. Pain Med. 2017 Nov 1. doi: 10.1093/pm/pnx279. [Epub ahead of print] No abstract available. Comment: Described in the title, this is a commentary on a quasi-experimental study in Veterans’ Administration clinics.  Read More

06.07.17

PubMed Update February-May 2017

Sorry this took so long. This was partly due to my schedule and partly because we’ve been in a process of transitioning to PrescribeToPrevent. You can thank those unnamed persons who reached out to me asking when the next installment was coming for avoiding a much greater delay!   108 articles in four months. TheRead More

11.06.16

PubMed Update October/November 2016

43 papers this round, and there are some goodies in here for sure (don’t miss #38!). Given the number and varied issues addressed, I divided them up into topic areas and, given the number on naloxone, I divided up the naloxone topic areas as well. Naloxone interventions Primary care 1) Co-prescription of naloxone as aRead More

09.04.16

PubMed Update September 2016

15 papers this month. 1) Drugs, Guns and Cars: How Far We Have Come to Improve Safety in the United States; Yet We Still Have Far to Go. Dodington J, Violano P, Baum CR, Bechtel K. Pediatr Res. 2016 Sep 27. doi: 10.1038/pr.2016.193. [Epub ahead of print] Review. Comment: Review of safety efforts in publicRead More

07.09.16

PubMed Update July 2016

11 papers this month, including an announcement that naloxone is now over-the-counter in Australia. 1) Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Harm Reduct J. 2016 Jul 26;13(1):24. doi: 10.1186/s12954-016-0113-2. Comments: Less than half knewRead More

05.13.16

PubMed Update May 2016

19 this month. Enjoy! 1) Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme. Tjagvad C, Skurtveit S, Linnet K, Andersen LV, Christoffersen DJ, Clausen T. Eur Addict Res. 2016 Jun 1;22(5):249-258. [Epub ahead of print] Comments: Patients on very high doses of methadone or also using benzodiazepines were at higher risk of death.Read More

04.09.16

PubMed Update April 2016

23 for this month! Lots of interesting stuff, from large-scale epidemiology to randomized controlled trials. 1) Pharmacokinetic Properties and Human Use Characteristics of an FDA Approved IntranasalNaloxone Product for the Treatment of Opioid Overdose. Krieter P, Chiang N, Gyaw S, Skolnick P, Crystal R, Keegan F, Aker J, Beck M, Harris J. J Clin Pharmacol. 2016 MayRead More

  • 1
  • 2
  • 3
  • 4
  • Next Page »

prescribetoprevent@gmail.com

site by: web360

  • Clinician Resource
    • General
    • Emergency Medicine
    • Substance Use Disorder Treatment
  • OTC Naloxone
  • Patient Education
    • Videos
    • Online Training
    • Materials
  • Policy Resources
    • Research
    • Legal
    • Position Statements
  • FAQ

Copyright 2022 PrescribeToPrevent.org